Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1432-1443
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1995 American Heart Association, Inc.
Articles |
Plasminogen Activator System in Human Coronary Atherosclerosis
From the Cardiovascular Division, Department of Medicine, and the Department of Pathology and Laboratory Medicine (J.E.T., R.J.C.), University of Pennsylvania School of Medicine, Philadelphia, Pa.
Abstract Altered coronary artery expression of plasminogen activator (PA) system components may predispose to thrombosis and modulate the vascular response to injury. By immunohistochemistry, we studied the expression of PAs (tPA and uPA), their major physiological inhibitor (PAI-1), and a receptor for uPA (uPAR) in human coronary arteries with either pure fibrointimal proliferation (n=15) or developed atherosclerotic plaques (n=10). Overall, the degree of staining showed the following rank order: PAI-1>tPA>uPAR>uPA. A similar pattern was seen in two normal coronary arteries. There were no significant differences in the extent of staining in any vascular compartment between atherosclerotic arteries and those with only fibrointimal proliferation. However, the ratio of intimal to medial expression of tPA (P=.001) and uPAR (P=.004) was significantly increased in atherosclerotic arteries, with a similar trend for uPA (P=.069) but not for PAI-1 (P=.73). Four of 10 atherosclerotic arteries had higher uPAR expression in the intima than in the media, whereas none of the 15 arteries with only fibrointimal proliferation had this pattern (P<.01). Dual labeling studies demonstrated colocalization of all four PA system components in endothelial cells, smooth muscle cells, and macrophages, with a predominance of PAI-1. Thus, coronary arteries with a wide range of vascular pathology express an abundance of antifibrinolytic potential with enhanced local expression of profibrinolytic proteins, mainly within atherosclerotic plaques.
Key Words: endothelium • plasminogen activator inhibitor • urokinase receptor • smooth muscle cells • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  Y. Kanno, T. Into, C. J. Lowenstein, and K. Matsushita Nitric oxide regulates vascular calcification by interfering with TGF-{beta} signalling Cardiovasc Res, January 1, 2008; 77(1): 221 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bujo and Y. Saito Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1246 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Dollery and P. Libby Atherosclerosis and proteinase activation Cardiovasc Res, February 15, 2006; 69(3): 625 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fisher, A. Paganini-Hill, A. Martin, M. Cosgrove, J. F. Toole, H. J.M. Barnett, and J. Norris Carotid Plaque Pathology: Thrombosis, Ulceration, and Stroke Pathogenesis Stroke, February 1, 2005; 36(2): 253 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hao, G. Gabbiani, and M.-L. Bochaton-Piallat Arterial Smooth Muscle Cell Heterogeneity: Implications for Atherosclerosis and Restenosis Development Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1510 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. May, T. Kalsch, S. Massberg, Y. Herouy, R. Schmidt, and M. Gawaz Engagement of Glycoprotein IIb/IIIa ({alpha}IIb{beta}3) on Platelets Upregulates CD40L and Triggers CD40L-Dependent Matrix Degradation by Endothelial Cells Circulation, October 15, 2002; 106(16): 2111 - 2117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tanaka, H. Koyama, T. Ichii, A. Shioi, M. Hosoi, E. W. Raines, and Y. Nishizawa Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Falkenberg, C. Tom, M. B. DeYoung, S. Wen, R. Linnemann, and D. A. Dichek Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth PNAS, August 6, 2002; 99(16): 10665 - 10670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang and E. G. Lakatta Altered Regulation of Matrix Metalloproteinase-2 in Aortic Remodeling During Aging Hypertension, April 1, 2002; 39(4): 865 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Padro, R. M. Mesters, B. Dankbar, H. Hintelmann, R. Bieker, M. Kiehl, W. E. Berdel, and J. Kienast The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells J. Cell Sci., January 5, 2002; 115(9): 1961 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Redmond, J. P. Cullen, P. A. Cahill, J. V. Sitzmann, S. Stefansson, D. A. Lawrence, and S. S. Okada Endothelial Cells Inhibit Flow-Induced Smooth Muscle Cell Migration : Role of Plasminogen Activator Inhibitor-1 Circulation, January 30, 2001; 103(4): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Tabengwa, R. L. Benza, H. E. Grenett, and F. M. Booyse Hypertriglyceridemic VLDL Downregulates Tissue Plasminogen Activator Gene Transcription Through cis-Repressive Region(s) in the Tissue Plasminogen Activator Promoter in Cultured Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1675 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oka, K. Kugiyama, H. Doi, T. Matsumura, H. Shibata, L. A. Miles, S. Sugiyama, and H. Yasue Lysophosphatidylcholine Induces Urokinase-Type Plasminogen Activator and Its Receptor in Human Macrophages Partly Through Redox-Sensitive Pathway Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 244 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Werner, T. M. Razzaq, and V. Ellis Tissue Plasminogen Activator Binds to Human Vascular Smooth Muscle Cells by a Novel Mechanism. EVIDENCE FOR A RECIPROCAL LINKAGE BETWEEN INHIBITION OF CATALYTIC ACTIVITY AND CELLULAR BINDING J. Biol. Chem., July 30, 1999; 274(31): 21555 - 21561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Kroon, P. Koolwijk, H. van Goor, U. H. Weidle, A. Collen, G. van der Pluijm, and V. W. M. van Hinsbergh Role and Localization of Urokinase Receptor in the Formation of New Microvascular Structures in Fibrin Matrices Am. J. Pathol., June 1, 1999; 154(6): 1731 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Chang, A. Kuo, E. S. Barnathan, and S. S. Okada Urokinase Receptor-Dependent Upregulation of Smooth Muscle Cell Adhesion to Vitronectin by Urokinase Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1855 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Thogersen, J.-H. Jansson, K. Boman, T. K. Nilsson, L. Weinehall, F. Huhtasaari, and G. Hallmans High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women : Evidence for the Fibrinolytic System as an Independent Primary Risk Factor Circulation, November 24, 1998; 98(21): 2241 - 2247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O C E Gebara, M A Mittleman, B W Walsh, I Lipinska, F K Welty, G Bellotti, J E Muller, F K Sacks, and G H Tofler Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia Heart, September 1, 1998; 80(3): 235 - 239. [Abstract] [Full Text]
|
|
|
|
|
|
E. Allaire, D. Hasenstab, R. D. Kenagy, B. Starcher, M. M. Clowes, and A. W. Clowes Prevention of Aneurysm Development and Rupture by Local Overexpression of Plasminogen Activator Inhibitor-1 Circulation, July 21, 1998; 98(3): 249 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-L. Bochaton-Piallat, G. Gabbiani, and M. S. Pepper Plasminogen Activator Expression in Rat Arterial Smooth Muscle Cells Depends on Their Phenotype and Is Modulated by Cytokines Circ. Res., June 1, 1998; 82(10): 1086 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Kanse, O. Benzakour, C. Kanthou, C. Kost, H. R. Lijnen, and K. T. Preissner Induction of Vascular SMC Proliferation by Urokinase Indicates a Novel Mechanism of Action in Vasoproliferative Disorders Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2848 - 2854. [Abstract] [Full Text]
|
|
|
|
|
|
F. B. Smith, A. J. Lee, F. G. R. Fowkes, J. F. Price, A. Rumley, and G. D. O. Lowe Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3321 - 3325. [Abstract] [Full Text]
|
|
|
|
|
|
T. Padro, M. Steins, C.-X. Li, R. M Mesters, D. Hammel, H. H Scheld, and J. Kienast Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants Cardiovasc Res, October 1, 1997; 36(1): 28 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kauhanen, V. Siren, O. Carpen, A. Vaheri, M. Lepantalo, and R. Lassila Plasminogen Activator Inhibitor-1 in Neointima of Vein Grafts : Its Role in Reduced Fibrinolytic Potential and Graft Failure Circulation, September 16, 1997; 96(6): 1783 - 1789. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. Ellis and S. A. Whawell Vascular Smooth Muscle Cells Potentiate Plasmin Generation by Both Urokinase and Tissue Plasminogen Activator-Dependent Mechanisms: Evidence for a Specific Tissue-Type Plasminogen Activator Receptor on These Cells Blood, September 15, 1997; 90(6): 2312 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R Garvin, M. Labinaz, K. Pels, V. M Walley, H. F Mizgala, and E. R O'Brien Arterial expression of the plasminogen activator system early after cardiac transplantation Cardiovasc Res, August 1, 1997; 35(2): 241 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Lijnen and D. Collen Impaired Fibrinolysis and the Risk for Coronary Heart Disease Circulation, November 1, 1996; 94(9): 2052 - 2054. [Full Text]
|
|
|
|
|
|
W.-Y. Zhang, I. Ishii, and H. S. Kruth Plasmin-mediated Macrophage Reversal of Low Density Lipoprotein Aggregation J. Biol. Chem., October 13, 2000; 275(42): 33176 - 33183. [Abstract] [Full Text] [PDF]
|
|